Skip to content

Gliomedin (GLDN)

Homo sapiens — UniProt Q6ZMI3

Gene: GLDNHomo sapiensSwissProt reviewed

Data last refreshed: (UniProt release unknown)

Key facts

Gliomedin (GLDN) is a protein from Homo sapiens identified by UniProt accession Q6ZMI3, 551 residues long. MolForge cross-references it against 0 known binders and 109 disease associations.

  • UniProt accession: Q6ZMI3; gene symbol GLDN.
  • Organism: Homo sapiens.
  • Length: 551 amino acids.
  • Top disease associations (Open Targets): lethal congenital contracture syndrome, Polyhydramnios and heel bone mineral density.
  • 3D structure: AlphaFold model available.

Target properties

Protein nameGliomedin
UniProt accessionQ6ZMI3
GeneGLDN
OrganismHomo sapiens
Length551 residues
Molecular weight—
EC numbers—
Target class—
Subcellular location—
Keywords—

Druggability

Target tractability assessment (Open Targets + pocket analysis). No approved drug

Druggability tierMEDIUM
Druggability score—
Pocket score—
Max clinical phase—

Disease associations (109)

Diseases linked to this target (Open Targets).

  • lethal congenital contracture syndrome · score 0.66
  • Polyhydramnios · score 0.44
  • heel bone mineral density · score 0.42
  • vital capacity · score 0.40
  • body height · score 0.38
  • fetal akinesia deformation sequence · score 0.37
  • fetal akinesia deformation sequence 1 · score 0.37
  • arthrogryposis multiplex congenita · score 0.30
  • bone quantitative ultrasound measurement · score 0.29
  • Flexion contracture · score 0.27

3D Structure (1)

Experimental (PDB) and predicted (AlphaFold) structures for this protein.

StructureSourceMethodMean pLDDTResolution (Å)
AF-Q6ZMI3-F1alphafoldPREDICTED72.71—

Experimental structures are not indexed in MolForge yet — search RCSB PDB for Q6ZMI3.

Amino-acid sequence (551 residues)

MARGAEGGRG DAGWGLRGAL AAVALLSALN AAGTVFALCQ WRGLSSALRA LEAQRGREQR EDSALRSFLA ELSRAPRGAS APPQDPASSA RNKRSHSGEP APHIRAESHD MLMMMTYSMV PIRVMVDLCN STKGICLTGP SGPPGPPGAG GLPGHNGLDG QPGPQGPKGE KGANGKRGKM GIPGAAGNPG ERGEKGDHGE LGLQGNEGPP GQKGEKGDKG DVSNDVLLAG AKGDQGPPGP PGPPGPPGPP GPPGSRRAKG PRQPSMFNGQ CPGETCAIPN DDTLVGKADE KASEHHSPQA ESMITSIGNP VQVLKVTETF GTWIRESANK SDDRIWVTEH FSGIMVKEFK DQPSLLNGSY TFIHLPYYFH GCGHVVYNNS LYYHKGGSNT LVRFEFGQET SQTLKLENAL YFDRKYLFAN SKTYFNLAVD EKGLWIIYAS SVDGSSILVA QLDERTFSVV QHVNTTYPKS KAGNAFIARG ILYVTDTKDM RVTFAFDLLG GKQINANFDL RTSQSVLAML AYNMRDQHLY SWEDGHLMLY PVQFLSTTLN Q

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

Which diseases are associated with GLDN?

The strongest Open Targets associations for GLDN are lethal congenital contracture syndrome, Polyhydramnios, heel bone mineral density, vital capacity and body height.

How long is the GLDN protein?

The Homo sapiens GLDN protein (UniProt Q6ZMI3) is 551 amino acids long.

Browse: Targets: G · all protein targets A–Z · drugs A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Explore Gliomedin with MolForge

Find binders, run structure-based screening, and map this target across diseases and approved drugs with our AI-powered platform.

Browse all targets

Quick facts

UniProtQ6ZMI3
GeneGLDN
OrganismHomo sapiens
Length551
Binders0
Diseases109
View on UniProt